Savara：历经三个月小挫折，高潜力二元押注正驶向 PDUFA（纳斯达克股票代码：SVRA）
· seekingalpha.com
Savara Inc. (SVRA) 研报更新，重点关注其针对 aPAP 的生物制品许可申请 (BLA) 提交进展。
This is my fifth Savara Inc. ( SVRA ) article, following 10/2025's "Savara: Back On Track With Upcoming APAP BLA Filing". In it I rated Savara as a "Buy"; it ha...